Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 OmicronHuiping Shuai, Hin Chu, Jialu Shi et al.|RePEc: Research Papers in Economics|0Cited by 647
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Hin Chu, Xiaoyu Zhao et al.|Nature Communications|2024Cited by 46
Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1Jialu Shi, Hin Chu, Xiaoyu Zhao et al.|Nature Communications|2025Cited by 6
Type‐II IFN inhibits SARS‐CoV‐2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3‐dioxygenase‐mediated pathwaysDong Yang, Hin Chu, Jasper Fuk‐Woo Chan et al.|Journal of Medical Virology|2024Cited by 4
Attenuated replication and pathogenesis of SARS-CoV-2 B.1.1.529 OmicronKwok‐Yung Yuen, Hin Chu, Huiping Shuai et al.|Research Square|2021Cited by 2